|
Arrhythmias, clinical electrophysiology, drugs
Citations 191-200 of 1416 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy. A Competing Risk Study
- Michael T. Koller, Beat Schaer, Marcel Wolbers, Christian Sticherling, Heiner C. Bucher, and Stefan Osswald
Circulation published April 7, 2008, doi:10.1161/CIRCULATIONAHA.107.742155
[Abstract]
- Images in Cardiovascular Medicine
Malicious Licorice
- Ivan Tancevski, Philipp Eller, Michael Spiegel, Rudolf Kirchmair, and Josef R. Patsch
Circulation 2008;117:e299, doi:10.1161/CIRCULATIONAHA.107.733097
[Full text]
- Articles
Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation
- Dawood Darbar, Prince J. Kannankeril, Brian S. Donahue, Gayle Kucera, Tanya Stubblefield, Jonathan L. Haines, Alfred L. George, Jr, and Dan M. Roden
Circulation published March 31, 2008, doi:10.1161/CIRCULATIONAHA.107.757955
[Abstract]
- Articles
Left Ventricular Systolic Function and Outcome After In-Hospital Cardiac Arrest
- Maria M. Gonzalez, Robert A. Berg, Vinay M. Nadkarni, Caio B. Vianna, Karl B. Kern, Sergio Timerman, and Jose A. Ramires
Circulation published March 31, 2008, doi:10.1161/CIRCULATIONAHA.107.740167
[Abstract]
- Arrhythmia/Electrophysiology
Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation: A Phase 3, Randomized, Placebo-Controlled Trial
- Denis Roy, Craig M. Pratt, Christian Torp-Pedersen, D. George Wyse, Egon Toft, Steen Juul-Moller, Tonny Nielsen, S. Lind Rasmussen, Ian G. Stiell, Benoit Coutu, John H. Ip, Edward L.C. Pritchett, A. John Camm for the Atrial Arrhythmia Conversion Trial Investigators
Circulation 2008;117:1518-1525; published online before print as doi:10.1161/CIRCULATIONAHA.107.723866
[Abstract]
[Full text]
- Images in Cardiovascular Medicine
Optical Mapping of the Human Atrioventricular Junction
- William J. Hucker, Vadim V. Fedorov, Kelley V. Foyil, Nader Moazami, and Igor R. Efimov
Circulation 2008;117:1474-1477, doi:10.1161/CIRCULATIONAHA.107.733147
[Full text]
- Editorials
Atrial Fibrillation Susceptibility in Metabolic Syndrome: Simply the Sum of Its Parts?
- John T. Nguyen and David G. Benditt
Circulation 2008;117:1249-1251, doi:10.1161/CIRCULATIONAHA.107.760777
[Full text]
- Arrhythmia/Electrophysiology
Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study
- Hiroshi Watanabe, Naohito Tanabe, Toru Watanabe, Dawood Darbar, Dan M. Roden, Shigeru Sasaki, and Yoshifusa Aizawa
Circulation 2008;117:1255-1260; published online before print as doi:10.1161/CIRCULATIONAHA.107.744466
[Abstract]
[Full text]
- Articles
Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation. A Phase 3, Randomized, Placebo-Controlled Trial
- Denis Roy, Craig M. Pratt, Christian Torp-Pedersen, D. George Wyse, Egon Toft, Steen Juul-Moller, Tonny Nielsen, S. Lind Rasmussen, Ian G. Stiell, Benoit Coutu, John H. Ip, Edward L.C. Pritchett, A. John Camm for the Atrial Arrhythmia Conversion Trial Investigators
Circulation published March 10, 2008, doi:10.1161/CIRCULATIONAHA.107.723866
[Abstract]
- Arrhythmia/Electrophysiology
Dietary Fish and  -3 Fatty Acid Consumption and Heart Rate Variability in US Adults
- Dariush Mozaffarian, Phyllis K. Stein, Ronald J. Prineas, and David S. Siscovick
Circulation 2008;117:1130-1137; published online before print as doi:10.1161/CIRCULATIONAHA.107.732826
[Abstract]
[Full text]
|
|
